UCSF

Department of Bioengineering and Therapeutic Sciences

Integrative mechanisms underlying the evolution of drug resistance in oncogene-driven lung cancer: a QBI Online Seminar with Trever Bivona

The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the U.S. and Ireland.

Kearney named interim dean of UCSF School of Pharmacy

The search for the School’s next dean is ongoing.

Faculty members inducted into the Chan Zuckerberg Biohub Investigator Program

Gartner, Huang, Manglik, Kortemme, Savic, and Shipman honored for visionary research endeavors

Chemistry-based strategies for investigating protein ADP-ribosylation: a QBI Online Seminar with Michael Cohen

The QBI Online Seminar Series presents Michael Cohen, an associate professor in the Department of Chemical Physiology and Biochemistry at Oregon Health and Science University (OHSU). Dr. Cohen received his BS in chemistry (cum laude) from UC Irvine and a PhD in chemical biology from UC San...

Shipman lab pioneers more efficient genome editing

Recent findings from the laboratory of Seth Shipman, PhD, show that a type of bacterial DNA known as a retron can be harnessed to dramatically improve genome editing.

Multi-scale modelling of cellular signalling, from protein structure to control of cell state transitions: a QBI Online Seminar with Oleksii Rukhlenko

The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the US and Ireland. QBI and UCD recently signed a 5-year MOU to reinforce the links between scientists in San Francisco and Dublin, and enhance...

Five School of Pharmacy trainees earn honors from the American Society for Clinical Pharmacology & Therapeutics

PhD students and postdoctoral researchers earn the 2022 Presidential Trainee Award

Map of protein systems reveals new targets for cancer treatment

Scientists at the UCSF Quantitative Biosciences institute developed a new approach for understanding cancer and applied it to breast cancer and cancers of the neck and head

Innate Immune Regulatory Circuits and Viral Antagonism: a QBI online seminar with Michaela Gack

The QBI and Gladstone Institute Infectious Disease and Human Health Seminar Series present Michaela Gack, PhD, Scientific Director and Chair of the Cleveland Clinic at the Florida Research and Innovation Center. Dr. Gack’s research focuses on understanding how the intricate interplay between...

Pages